February 28, 2020 / 12:22 PM / a month ago

BRIEF-Sangamo Therapeutics Reports Q4 EPS Of $0.04

Feb 28 (Reuters) - Sangamo Therapeutics Inc:

* SANGAMO THERAPEUTICS REPORTS FOURTH QUARTER AND FULL YEAR 2019 FINANCIAL RESULTS

* Q4 EARNINGS PER SHARE $0.04

* Q4 EARNINGS PER SHARE ESTIMATE $-0.33 — REFINITIV IBES DATA

* SANGAMO THERAPEUTICS - ON A GAAP BASIS, CO EXPECTS TOTAL OPERATING EXPENSES TO BE IN RANGE OF $270 TO $285 MILLION IN 2020

* SANGAMO THERAPEUTICS - NON-GAAP TOTAL OPERATING EXPENSES ARE EXPECTED TO BE IN RANGE OF $245 TO $260 MILLION IN 2020 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below